APA (7th ed.) Citation

S, P., C, L., M, F., F, P., M, B., M, L., . . . F, G. (2026). Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics. AIDS (London, England), 40(5), 622. https://doi.org/10.1097/QAD.0000000000004437

Chicago Style (17th ed.) Citation

S, Padilla, et al. "Point-of-care Ultrasound Guidance for Long-acting Cabotegravir-rilpivirine Administration Improves Injection-site Tolerability and Preserves Pharmacokinetics." AIDS (London, England) 40, no. 5 (2026): 622. https://doi.org/10.1097/QAD.0000000000004437.

MLA (9th ed.) Citation

S, Padilla, et al. "Point-of-care Ultrasound Guidance for Long-acting Cabotegravir-rilpivirine Administration Improves Injection-site Tolerability and Preserves Pharmacokinetics." AIDS (London, England), vol. 40, no. 5, 2026, p. 622, https://doi.org/10.1097/QAD.0000000000004437.